Document is current
Any future updates will be listed below
-
Authors
Weng, Xiaocheng
Gong, Jing
Chen, Yi
Wu, Tong
Wang, Fang
Yang, Shixi
Yuan, Yushu
Luo, Guanzheng https://orcid.org/0000-0002-6797-9319
Chen, Kai
Hu, Lulu
Ma, Honghui
Wang, Pingluan
Zhang, Qiangfeng Cliff https://orcid.org/0000-0002-4913-0338
Zhou, Xiang
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (21572172)
National Natural Science Foundation of China (21778040)
National Natural Science Foundation of China (21822704)
National Natural Science Foundation of China (31671355)
National Natural Science Foundation of China (91740204)
National Natural Science Foundation of China (31761163007)
National Natural Science Foundation of China (21432008)
National Natural Science Foundation of China (91753201)
National Natural Science Foundation of China (21721005)
U.S. Department of Health & Human Services | National Institutes of Health (HG008935)
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 19 January 2019
Accepted: 20 December 2019
First Online: 3 February 2020
Competing interests
: C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics, Inc., and a shareholder of Epican Genetech.
